Get the Stockscreener App
18.00
1.15%
-0.21
After Hours:
18.00
Apollomics Inc stock is traded at $18.00, with a volume of 11,947.
It is down -1.15% in the last 24 hours and down -13.46% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
See More
Previous Close:
$18.21
Open:
$18.072
24h Volume:
11,947
Relative Volume:
0.72
Market Cap:
$39.53M
Revenue:
$8.50M
Net Income/Loss:
$-10.94M
P/E Ratio:
-2.3778
EPS:
-7.57
Net Cash Flow:
$-28.76M
1W Performance:
-4.56%
1M Performance:
-13.46%
6M Performance:
-9.41%
1Y Performance:
+188.92%
1-Day Range:
$18.00
$18.76
1-Week Range:
$17.80
$19.50
52-Week Range:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
18.00 | 39.99M | 8.50M | -10.94M | -28.76M | -7.57 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Apollomics Inc Stock (APLM) Latest News
Apollomics Inc (APLM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apollomics Inc (APLM) Balance Sheet - TradingKey
Apollomics Inc (APLM) Institutional Confidence - TradingKey
Apollomics Inc (APLM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apollomics Inc (APLM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apollomics Inc. Revenue Breakdown – NASDAQ:APLM - TradingView
Apollomics Inc (APLM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apollomics Inc (APLM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apollomics Inc. Revenue Breakdown – BOATS:APLM - TradingView
TradingKey - TradingKey
APLM|Apollomics Inc|Price:18.210|Chg%:-0.310 - TradingKey
Apollomics Inc (APLM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apollomics Inc (APLM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apollomics Inc. (APLM) director discloses grant of 500 restricted stock units - Stock Titan
Apollomics appoints Hung-Hsien Yen to board after two directors resign - Bitget
Apollomics Inc. (APLM) appoints Hung-Hsien Yen to board - Stock Titan
Apollomics Inc. Warrants (APLMW) Surge 33.8% to $0.02: A High-Risk Penny Stock MoveTriple MA Cross - dars.gov.et
Apollomics Inc. (APLM) Plunges Over 21%: Key Support Levels Tested Amid Heavy SellingIV Rank - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
Apollomics (Nasdaq: APLM) restores compliance with Nasdaq $35M MVLS rule - Stock Titan
Apollomics regains compliance with Nasdaq listing requirements - TipRanks
Apollomics Regains Full Compliance with Nasdaq Listing Requirements - GlobeNewswire
Apollomics Regains Full Compliance With Nasdaq Listing Requirements - Moomoo
Apollomics Company Profile & Introduction - Moomoo
Avoiding Lag: Real-Time Signals in (APLM) Movement - Stock Traders Daily
Apollomics Inc. (APLM) Sheds 3.65% as Selling Pressure Mounts Near ResistanceSynthetic Short - DonanımHaber
Apollomics Inc. Warrant 2023-01.04.28 on Apollomics Financial Disclosures & SEC Filings - TradingView
Apollomics Inc. (APLM) Plunges Over 10%, Testing Key Support at $18.14Dynamic Hedging - dars.gov.et
Apollomics Inc. (APLM) Shows Modest Uptick as It Tests $21 Resistance ZoneSign of Weakness - dars.gov.et
Number of shareholders of Apollomics Inc. – NASDAQ:APLM - TradingView
Enterprise value to revenue forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Enterprise value to EBIT forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Price to book forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Price to earnings forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Enterprise value to EBITDA forward of Apollomics Inc. – BOATS:APLM - TradingView
APLM Forecast — Price Target — Prediction for 2027 - TradingView
Apollomics Inc. Class A Actuals & Estimates (BOATS:APLM) - TradingView
Apollomics Warrant (APLMW) Inches Upward Amidst Sluggish Trading at $0.01Thematic ETF Flow - dars.gov.et
Apollomics Terminates License Agreement With Launxp International - Moomoo
Nasdaq flags Apollomics (NASDAQ: APLM) as MVLS falls short and Launxp deal ends - Stock Titan
Apollomics Receives Nasdaq Deficiency Notice Regarding - GlobeNewswire
Apollomics Inc (APLMW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Discipline and Rules-Based Execution in APLM Response - Stock Traders Daily
Apollomics Inc (APLMW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apollomics Inc (APLMW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apollomics Inc (APLMW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Apollomics (APLM) CFO RSU vesting triggers 3,588-share tax withholding - Stock Titan
Apollomics Inc (APLM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apollomics (APLM) CEO Hung-Wen Chen gains 5,000 shares as RSUs vest - Stock Titan
Apollomics (APLM) director acquires 500 shares through RSU vesting - Stock Titan
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):